Endocrine, Reproductive, Neurophysiologic and Extraneous Activities of Estrogen in Vertebrates by Nwankudu, O.N.





NIGERIAN VETERINARY JOURNAL 
ISSN 0331-3026 




Endocrine, Reproductive, Neurophysiologic and Extraneous Activities 
of Estrogen in Vertebrates 
Nwankudu. O.N.  
Department of Veterinary Physiology and Pharmacology, Michael Okpara University of Agriculture, Umudike, Abia 
State, Nigeria 
Corresponding author: Email: droluchi123@gmail.com; Tel. No.: +234 7035294923 
SUMMARY  
Estrogens are reproductive hormones synthesized in the gonads of both male and female 
vertebrates. This review is geared towards uncovering some endocrine, reproductive, 
neurophysiologic and extraneous activities of estrogen in vertebrates. The three most common 
naturally occurring estrogens are: Estrone (E1), estradiol (E2), and estriol (E3). In primates, 
estradiol is the most potent and predominant estrogen during reproductive years. Estrogens are 
synthesized primarily in the female ovaries and in small quantities in the male testes and the 
adrenal glands, brain, and fat of both sexes. Estrogens are steroid hormones. The adipose tissues 
are considered to be the major source of circulating estrogen after the gonads in both men and 
women. In essence, the presence of aromatase expression in a local tissue confirms extra-gonadal 
estrogen synthesis. In reproduction, estrogen promote secondary sexual characteristics in females 
and regulates maturation of sperm (spermiogenesis) in males. Neurophysiologically, estrogen 
promote glutamate activity in the central nervous system, facilitates dopaminergic 
neurotransmission but blocks gammaaminobutyric acid. Extraneously, estrogen decrease serum 
cholesterol and osteoporosis especially in menopausal females. However, acute estrogen drop 
postpartum leads to depressed mood experienced by most post parturient females. In this review, it 
is observed that, while serum estrogen decreases with age in females, in male it increases with age 
due to the extraneous synthesis of estrogen especially in the adipose tissue.  
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INTRODUCTION                                            
Estrogens are the key hormones regulating the 
development and function of reproductive organs 
in all vertebrates. Estrogen is a generic term for  
 
estrus-producing compounds. Estrogen is 
produced by the ovaries and in smaller quantities, 
by the adrenal cortex, testes, and feto-placental 
unit (Azcoitia et al., 2011: Haraguchi et al., 
2012). 




Most animals depend on the versatile estrogens 
to influence growth, development, behavior, 
regulate reproductive cycles; and affect many 
other body systems (Juraska et al., 2013). 
Understanding non-gonadal sites of estrogen 
synthesis and function is crucial and will lead to 
therapeutic interventions targeting estrogen 
signaling in disease prevention and treatment 
(Barakat et al., 2016). 
Seventeen-beta (17-β) estradiol is the most 
abundant and potent natural estrogen in all 
vertebrates.  The adipose tissues are considered 
to be the major source of circulating estrogen 
after the gonads in both men and women, and the 
contribution made by the adipose tissues to the 
total circulating estrogens increases with 
advancing age (Osterlund et al., 2000: Dieudonne 
et al., 2004). 
Estrogens are synthesized in all vertebrates as 
well as some insects. Three major naturally 
occurring forms of estrogen in women are 
estrone (E1), estradiol (E2), and estriol (E3). 
Another type of estrogen called estetrol (E4) is 
produced only during pregnancy. Quantitatively, 
estrogens circulate at lower levels than androgens 
in both men and women. While estrogen levels 
are significantly lower in males compared to 
females, estrogens nevertheless also have 
important physiological roles in males (Marino et 
al., 2006). 
Estrogens, in females, are produced primarily by 
the ovaries in non-pregnant animal species and 
the placenta during pregnancy. Follicle-
stimulating hormone (FSH) stimulates the 
ovarian production of estrogens by the granulose 
cells of the ovarian follicles and corpora lutea. 
Some estrogens are also produced in smaller 
quantities by other tissues such as the liver, 
adrenal glands and the breasts. In females, FSH 
stimulates granulosa cells in the ovarian follicles 
to synthesize aromatase which converts 
androgens produced by the thecal cells to 
estradiol (Karligiotou et al., 2011: Anushka and 
Kumar, 2017). 
In primates, estradiol is the predominant estrogen 
during reproductive years both in terms of 
absolute serum levels as well as in terms of 
estrogenic activity. During menopause, estrone is 
the predominant circulating estrogen and during 
pregnancy estriol is the predominant circulating 
estrogen. Estriol is the most abundant of the three 
estrogens, but it is also the weakest but estradiol 
is the strongest with a potency of approximately 
80 times that of estriol. Thus, estradiol is the 
most important estrogen in non-pregnant 
females. All of the different forms of estrogen 
are synthesized from androgens, specifically 
testosterone and androstenedione by the enzyme 
aromatase (Hampson and Morley, 2013). 
Some estrogen metabolites, such as the catechol 
estrogens, 2-hydroxyestradiol, 2-hydroxyestrone, 
4-hydroxyestradiol and 4-hydroxyestrone as well 
as 16α-hydroxyestrone are also estrogens with 
varying degrees of activity. The biological 
importance of these minor estrogens is not 
entirely clear (Cornil et al., 2006). 
 Estrogen in men 
Males secrete estrogens, too. About 70% of the 
estradiol in the plasma of adult men are formed 
by aromatization of circulating testosterone and 
androstenedione. The plasma estradiol level in 
men is approximately 2ng/dl which is equivalent 
to 70pmol/L and the total production rate is 
0.05mg/d (0.18μmol/d). Estrogen influence 
fertility through the prostate, testis, and other sex 
tissues. Estrogen can be recovered from a man’s 
urine. The concentration of estrogen in the fluid 
found in seminiferous tubules is quite high and 
plays a role in spermatogenesis (Cherrier et al., 
2005i). Unlike women, there is a moderate 
increase in estrogen production in men with 
advancing years (Ganong, 1993: Hess et al., 
1997).  
Also, in male reproduction, the Sertoli cells 
possesses aromatase which converts testosterone 
to estrogen. Very large quantities of estrogen is 
found in stallions (male horse). Therefore, 
fertility of a horse can be assessed by measuring 




circulating concentrations of either testosterone 
or estrogen (Bracket, 2004). 
Estrogenic functions   
Generally, estrogens have wide-range of effects 
throughout life and in both sexes. Most 
vertebrates depend on this hormones to control 
and regulate female development, reproduction, 
and sex characteristics. Their signals also affect 
blood fat levels (Bracht et al., 2019), enzyme 
production (Strehlow et al., 2003), water and salt 
balance (Santollo and Daniels, 2015), bone 
density and strength (Camacho, 2017), skin and 
blood vessel elasticity, heart muscle, and brain 
functions such as memory and sexual and 
maternal behavior (O’Lone et al., 2004). 
Like all steroid hormones, the receptor for 
estrogens are domiciled in the cell nucleus.  
Estrogens readily diffuse across the cell 
membrane. Once inside the cell, they bind to and 
activate estrogen receptors (ERs) which in turn 
modulate the expression of many genes.  
Additionally, estrogens bind to and activate 
rapid-signaling membrane estrogen receptors 
(mERs) such as Guanoline-protein (G-protein) 
coupled estrogen receptor (GPER) which binds 
to 17-beta-estradiol (E2) with high affinity, 
leading to rapid and transient activation of 
numerous intracellular signaling pathways. G-
protein coupled estrogen receptor 1 is also 
known as G-protein-coupled receptor 30 (GPER 
30). GPER is ubiquitously expressed throughout 
the body, including the heart, brain, pancreas, 
skeletal muscle, kidney, vessels, and 
reproductive organs where it stimulates cyclic 
adenosine monophosphate (AMP) production, 
calcium mobilization and subsequent 
transactivation of the epidermal growth factor 
receptor (EGFR). Disease processes also regulate 
the expression of this receptor, as GPER is 
significantly up-regulated in lung cancer and 
endometriosis (Shang et al 2000: Prossnitz and 
Hathaway, 2015: Zimmerman et al., 2016: Yaser 
et al., 2017: Fuentes and Silveyra, 2019). 
 
 
Endocrine activity of estrogen 
Estrogens are steroid hormones. All steroid 
hormones are derived from cholesterol. The 
synthesis of estrogen is a one way chemical 
reaction. It is non-reversible (Cue et al., 2013).  
The precursor for estrogen and other steroid 
hormones is cholesterol. The synthesis of 
estrogen follows two pathways as shown below: 
(1). Cholesterol, catalyzed by cholesterol 
desmolase give rise to Pregnenolone. Enzymatic 
catalysis of Pregnenolone by 17α-hydroxylase 
gives rise to 17-hydroxy-pregnenolone which 
also is catalyzed by 17, 20 lyase to give rise to 
Dehydroepiandrosterone which directly gives 
rise to Androstenedione in a non-enzymatic 
reaction. Androstenedione through a reversible 
non enzymatic reaction gives rise to 
Testosterone. Testosterone undergoes 
aromatization to yield estrogen in a non-
reversible reaction (Sik Yoo and Napoli, 2019: 
Conklin and Knezevic, 2020). 
(2). Cholesterol catalyzed by cholesterol 
desmolase give rise to Pregnenolone. Enzymatic 
catalysis of Pregnenolone by 3-β hydroxyl-
steroid yields Progesterone. Progesterone 
catalyzed by 17-α hydroxylase yields 17-
hydroxy-Progesterone which is catalyzed by 17, 
20 lyase just as in step 1to yield Androstenedione 
which undergoes a reversible reaction to yield 
Testosterone. Testosterone through aromatization 
yields Estradiol in a non-reversible reaction 
(Santem and Simpson, 2019). 
 The half-life of estrogens is specie specific; 
about 1-3 hours. Like all steroid hormones, the 
receptor for estrogens are domiciled in the cell 
nucleus. The presence of aromatase expression in 
a local tissue confirms extra-gonadal estrogen 
synthesis (Shay et al., 2018). In the adipose 
tissues, estradiol stimulates the production of 
high density lipoprotein (HDL) and triglycerides 
and decreases low density lipoprotein (LDL) 
production (Ma et al., 1995). 
Furthermore, aromatase expression in bone has 
been demonstrated in osteoblasts, chondrocytes, 
and fibroblasts where they convert circulating 




androgens into estrogens. In the bone of pre-
pubertal animals, the locally synthesized 
estradiol stimulates epiphyseal maturation during 
the growth phase. However, in both males and 
females, the massive pubertal increase of 
estradiol leads to increased apoptosis of 
chondrocytes in the epiphyseal plate, causing 
chondrocyte depletion leading to ossification and 
growth slow-down especially in the females 
(Song et al., 2019). 
 In females, synthesis of estrogens starts in theca 
interna cells in the ovary, by the synthesis of 
androstenedione from cholesterol. 
Androstenedione is a substance of weak 
androgenic activity which serves predominantly 
as a precursor for more potent androgens such as 
testosterone as well as estrogen. This compound 
crosses the basal membrane into the surrounding 
granulosa cells, where it is converted either 
immediately into estrone, or into testosterone and 
then estradiol in an additional step. The 
conversion of androstenedione to testosterone is 
catalyzed by 17β-hydroxysteroid dehydrogenase 
(17β-HSD), whereas the conversion of 
androstenedione and testosterone into estrone 
and estradiol, respectively is catalyzed by 
aromatase. These enzymes are both expressed in 
granulosa cells. In contrast, granulosa cells lack 
17α-hydroxylase and 17, 20-lyase, whereas theca 
cells express these enzymes and 17β-HSD but 
lack aromatase. Hence, both granulosa and theca 
cells are essential for the production of estrogen 
in the ovaries (Nicol et al., 2009: Hu et al., 
2010). 
Estrogen in reproduction  
During embryonic life, estrogens stimulate 
adrenal cortex growth during development by 
promoting cell proliferation and enhancing 
steroidogenic activity by increasing the 
steroidogenic acute regulatory protein (StAR) 
and steroidogenic factor-1 (SF-1) expression in 
the adrenal gland. In the fetal adrenal gland, 
estradiol and Adrenocorticotropic hormones 
(ACTH) form a positive regulatory loop in which 
estradiol increases ACTH secretion from adrenal 
cortex while ACTH increase estradiol in the 
ovary (Kaludjerovic and Ward, 2012). 
In the females at puberty, increased estradiol 
synthesis as a primer for puberty, regulates 
growth hormone and determines final height, by 
shutting off bone growth at the ephiphysis of 
arms and legs in humans and fore and hind limbs 
in quadrupeds. Also, estrogens are responsible 
for the development of other female secondary 
sexual characteristics during puberty which 
include: widening of the hips and female fat 
distribution. At the other hand, androgens 
(testosterone and androstenedione) are 
responsible for pubic and body hair growth as 
well as acne and axillary odor observed in 
pubertal females (Blackburn, 2014).  
Furthermore, in females, the ovaries are the 
prime location for estrogen production. The 
estrogens are released from ovarian follicles and 
the corpus luteum following the release of an egg 
from the follicle, and the placenta. Follicle-
stimulating hormone (FSH) causes the release of 
estrogen and, conversely, estrogen inhibits the 
release of FSH in a negative feedback loop 
(Strauss and Barbieri, 2013).  
Estrogens, in adult females, are produced 
primarily by the ovaries prior pregnancy and the 
placenta during pregnancy. Follicle-stimulating 
hormone (FSH) stimulates the ovarian 
production of estrogens by the granulose cells of 
the ovarian follicles and corpora lutea. Some 
estrogens are also produced in smaller quantities 
by other tissues such as the liver, adrenal glands 
and the breasts.  (Simpson, 2003). 
While estrogens are present in both male and 
female, they are usually present at significantly 
higher levels in females of reproductive age. 
They promote the development of female 
secondary sexual characteristics such as breast 
development, thickening of the endometrium, 
stimulates the growth of the vagina to its adult 
size and the thickening of the vaginal wall. It also 
plays a part in vaginal lubrication, stimulates the 
growth of the ovarian follicle, regulate the flow 
and thickness of cervical mucus secretion to 




enhance sperm transport and stimulates the 
muscles in the uterus to develop and contract 
during parturition (Baker, 2013).  
During pregnancy, estrogen is made and released 
by the corpus luteum of the ovaries and the fetal-
placental unit. The fetal-placental unit is where 
the fetal liver and adrenal glands produce an 
estrogen called estriol. Generally estrogen levels 
increase throughout pregnancy and have the 
following effects: Supports, regulates, and 
stimulates the production of pregnancy hormone 
(progesterone), functions in the development of 
fetal organs such as the liver, kidneys, and lungs, 
facilitates placental growth and function and 
Prepares the mother for lactation (breast-feeding) 
by enhancing maternal breast tissue growth 
(Findlay et al 2016).  
For commencement of parturition, Estrogen and 
oxytocin cause the release of prostaglandins in 
the uterus. In turn estrogen, oxytocin and 
prostaglandins stimulate the maturation of the 
cervix leading to successive dilation during 
parturition by relaxin. After expulsion of the 
placenta during parturition, the blood levels of 
progesterone and estrogen fall which allows the 
mother to produce colostrum, a high-density milk 
that is rich in proteins, minerals, and vitamins 
(specifically Vitamin A and K) and 
immunoglobulin for the neonate (Kota et al., 
2013).  
 In males, estrogen exert pleiotropic effects by 
acting on several tissues and organs including the 
reproductive system (Rochira et al., 2016). 
Estrogen regulates certain functions of the 
reproductive system important to the maturation 
of sperm (spermiogenesis) and may be necessary 
for a healthy libido (cacciola et al., 2013). The 
Sertoli cells convert testosterone to estrogens. 
Estrogens move into the adluminal and basal 
compartments of seminiferous tubules and can 
move outwards to enrich estrogenic content in 
the blood stream (Lombardi et al., 2001: 
Brackett, 2004). 
 
Estrogen affects sexual behavior 
Apart from humans, female mammals have no 
mating desire except during estrus when there is 
estrogen surge. Estrogen promotes sexual 
receptivity of vertebrates in estrus and induces 
lordosis in some species; a behavior which is 
regulated by the ventromedial nucleus of the 
hypothalamus. Estrogen also regulates ovulation 
(Kow and Pfaff, 1998: Christensen et al., 2011). 
In the male, sex drive thrives with increased 
androgen levels only in the presence of estrogen. 
Without estrogen, free testosterone level actually 
decreases sexual desire instead of increasing sex 
drive (Warnock et al., 2005).  
Estrogens secreted from the ovaries fluctuate 
during the reproductive cycle, which may occur 
episodically in frogs mating in response to 
rainfall (Wilczynski and Lynch, 2011), bi-weekly 
in many marine animals (Bondesson et al., 2015), 
monthly in humans, semi-annually in cattle 
(Northrop, 2019), or even bi-annually in 
elephants (Kangwanakadzo, 1996). Estrogen 
levels rise in response to internal or external cues 
which include: temperature, light cycle or 
presence of potential mates (Heiman et al., 
2011).  
Neurophysiologic activity of estrogen 
Estrogen has multiple effects on the brain (Zarate 
et al., 2017), including priming the body for 
sexual reproduction. In the brain estrogen 
functions in maintenance of body temperature. 
Estrogen may delay memory loss (Henderson, 
2009), regulates parts of hypothalamus and 
limbic system which prepare the body for sexual 
and reproductive activity, increases serotonin and 
the number of serotonin receptors in the brain, 
modifies production and the effect of endorphins 
in the brain, protects nerves from damage and 
possibly stimulates nerve growth (Rettberg et al., 
2014).  
High levels of estrogen receptors are expressed 
during brain development in both male and 
female.  In fact 17β-estradiol plays critical 
organizational role during early brain 
development and has been shown to be pivotal in 




the sexually dimorphic development and 
regulation of the neural circuitry underlying sex-
typical and socio-aggressive behaviors in males 
and females (Denley et al., 2018).  During this 
period, sex hormones determine apoptosis, 
neuronal migration, neurogenesis, axonal 
guidance, and synaptogenesis. Estradiol induces 
sexual differentiation in the developing brain. 
Aromatase mRNA expression in the 
hypothalamus of males peaks before and after 
birth, inducing sexual differentiation of the brain. 
In the brains of both males and females, estradiol 
provides a neuroprotective effect. It prevents 
neurodegeneration in brain tissues (Azcoitia et 
al., 2003).   
 Estradiol regulates neuronal metabolism by 
modulating the expression of metabolic enzymes 
such as GLUT (glucose-transporter), glycolytic 
enzyme hexokinase, pyruvate dehydrogenase 
(PDH), aconitase (an enzyme involved in 
tricarboxylic acid cycle), and adenosine 
triphosphste(ATP) synthase (Mela et al., 2016). 
Effect of estrogen on neurotransmitters 
The tropic effects of ovarian hormones emerge 
early in brain development and remain 
throughout adolescence and adulthood.  Many of 
these actions occur in brain regions involved in 
learning  and memory (the cerebrum), emotion 
(hypothalamus and limbic system), motivation 
(hypothalamus and limbic system), motor control 
(medulla oblongata and midbrain), and cognition 
(limbic system). Furthermore, several lines of 
evidence support a main impact of ovarian 
hormone (estrogen and progesterone) on brain 
development and plasticity. Specific structural 
effects of estrogen and progesterone include 
neurite outgrowth and synaptogenesis, dendritic 
branching and myelination (Denley et al., 2018). 
Both estrogen and progesterone act through 
classical genomic receptors as well as non-
classical membrane-associated receptors. The 
classical estrogen receptors (ERα/β) and 
progesterone receptors (PRA/B) are highly 
expressed in brain areas involved in emotion and 
cognition, such as hippocampus and amygdala 
(Lymer et al., 2018). Ovarian hormones can act 
on multiple receptor types, such as voltage-gated 
ion channels, including Gamma-amino butyric 
acid A (GABAA) N-methyl-D-aspartate 
(NMDA), serotonin and dopamine receptors (Li 
and Tsien, 2009). While these genomic actions of 
sex hormones require a comparably long time 
(from minutes to hours) and are limited by the 
rate of protein biosynthesis, non-genomic 
modulation of the membrane receptors is mostly 
faster and requires only milliseconds to seconds 
(Hara et al., 2015).  
Both estrogen and progesterone exert acute 
effects on synaptic physiology through the 
activation of multiple intracellular signaling 
pathways which includes the MAPK/ERK and 
the Akt pathway which are both part to a non-
genomic signaling cascade linked to the 
promotion of cell survival. MAPK/ERK is a 
chain of proteins in the cell which communicates 
a signal from a receptor on the cell surface to the 
DNA in the nucleus. The pathway includes many 
proteins such as Mitogen activated protein kinase 
(MAPK) originally called Extracellular signal-
regulated kinase (ERK) which communicates 
through phosphorylation (Lavoie et al., 2020). 
Also Akt is a serine/threonine kinase previously 
known as protein kinase B (PKB), consisting of 
three isoforms (Akt1, Akt2 and Akt3), with a 
crucial role in major cellular functions including 
cell size, cell cycle progression, regulation of 
glucose metabolism, genome stability, 
transcription, protein synthesis and 
neovascularization (Nitulescu et al., 2018). A 
distinct progesterone-binding protein different 
from the classical PR was identified as a 
membrane protein, known as 7TMPR: a G-
protein coupled progesterone receptor (Brinton et 
al., 2008) which mediates non-genomic actions 
through second-messenger cascades. However, 
genomic and non-genomic actions of hormones 
may also be coupled, so the distinctions are not 
as clear-cut as was first thought (Singh, 2001). 
Estrogens also exhibit profound effect on 
neurotropins such as brain-derived neurotropic 




factor (BDNF). BDNF has been shown to play a 
key role in neuronal survival, in promoting 
neuronal regeneration following injury and 
regulating neurotransmitter system (Kwakowsky, 
et al., 2016). Estrogen treatment seems to 
increase BDNF expression in several brain 
regions including hippocampus, amygdala and 
cortex. Estrogen has also been shown to decrease 
the risk for neurodegenerative diseases such as 
Parkinson's disease and Alzheimer's disease 
(Handa et al., 2012). 
Although estrogen and progesterone target 
multiple regions in the brain, one brain region 
that has been the focus of many studies 
investigating potential neurotropic effects of 
these hormones is the hippocampus, a brain 
region associated with various memory 
functions. Both, acute estrogen and progesterone 
treatment have been shown to increase synapse 
density and spine formation in hippocampal 
structures in rodents respectively (Sheppard et 
al., 2019). However, the generative effects of 
progesterone seem to disappear after chronic 
treatment. Furthermore, progesterone has also 
been shown to down-regulate estrogen-induced 
synapses when added to estrogen-administration 
chronically (Karpinski et al. 2017). Thus, the 
duration and combination of ovarian hormone 
supplementation seems to be essential for its 
neuroplastic effects on brain structures, such as 
the hippocampus. Therefore, the overall 
modulatory effect of ovarian hormones is more 
complex than simple mechanistic processes of 
up- and down-regulation of expression patterns 
in isolated brain regions (Yague et al., 2008). 
In humans, evidence for hormone-dependent 
modulatory effects on brain structure stems from 
hormonal replacement therapy (HRT) studies. 
The importance of ovarian hormones has led to 
its use as HRT, primarily to treat menopausal and 
postmenopausal symptoms such as hot flashes 
and night sweat. However, structural and 
functional changes associated with HRT 
regimens have sparked a heightened interest in 
ovarian hormone effects in the human body 
(Labhart, 2012). 
Beyond structural changes mediated by HRT, 
estrogen supplementation is also known to have 
prominent effects on mood and cognitive 
functioning in domains such as working memory 
and executive control (Uban et al., 2012).  
Estrogen and glutamate interaction 
Glutamate acts as the main excitatory 
neurotransmitter in the Central Nervous System 
(CNS) and is a proximal regulator of cognitive 
domains such as learning and memory. The 
integration of glutamatergic transmission is 
fundamental for normal cognitive functioning 
and mental health. The cortical glutamate 
projections are organized in descending and 
ascending pathways that project throughout 
much of the telencephalon (the lobes of the 
cerebral cortex). The impact of ovarian hormones 
(estrogen and progesterone) on the glutamatergic 
system has been studied extensively, especially 
in cell cultures and animal models. Both 
stimulatory and inhibitory effects of ovarian 
hormones have been reported (Bethea and 
Reddy, 2012). 
 In rodents, several mechanisms through which 
ovarian hormones may influence glutamatergic 
neurotransmission have been studied; 
progesterone has been shown to suppress the 
excitatory glutamate response in a dose-
dependent fashion while estrogen exhibits 
facilitating effects on glutamate transmission 
(Farkas et al., 2018). A physiological dose of 
progesterone in ovariectomized rats has been 
reported to reduce glutamate-response by 87% 
through attenuation of non-NMDA receptors 
(AMPA- Kainate). N-methyl-D-aspartate 
(NMDA) receptors are glutamate receptors and 
ion channel protein found in nerve cells while 
AMPA (α-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid) is a sub-type of 
glutamate receptor responsible for the majority of 
fast-excitatory transmission in the central 
nervous system. The kainite receptor which is an 
ionotropic receptor that respond to the 




neurotransmitter; glutamate is similar and the 
term AMPA-kainate is sometimes used to 
describe them collectively (Lerma and Marques, 
2013). The magnitude of the attenuation of the 
non-NMDA receptors seems directly 
proportional to the progesterone dose. Whereas 
progesterone mainly impacts non-NMDA 
receptors, the mechanisms underlying estrogen 
effects on cognition are related to NMDA 
glutamate receptors. Estrogen has been shown to 
promote an increase in NMDA receptor subunit 
expression binding sites and neuronal sensitivity 
to synaptic input mediated by NMDA glutamate 
receptors. The blockade of NMDA receptors 
with antagonists attenuates the effects of estrogen 
on neuronal correlation of memory, such as long-
term potentiation (Abdallah et al 2014).  
A plethora of animal studies have shown that 
estrogen with and without progesterone increases 
dendritic spines through the up-regulation of 
AMPA and NMDA receptors in the hippocampus 
and prefrontal cortex (PFC) but ovariectomy 
reduced synaptic markers in these regions (Zhou 
et al., 2005: Alexander et al., 2018).  
Apart from cellular effects, recent studies report 
that the interaction between estrogen and 
glutamate can affect cognitive domains such as 
working memory and executive function under 
harmful conditions. Brain regions hypothesized 
to underlie these cognitive domains, for instance; 
the pre-frontal cortex (PFC) and hippocampus, 
seem largely dependent on normal estrogen 
signaling to counter insults such as stress. In a 
repeated stress paradigm, Wei et al., (2014) 
found a beneficial effect of endogenous estrogen 
on glutamate receptors in the PFC in female rats 
compared to male rats. Some authors propose 
that detrimental effects of repeated stress are 
present in females when estrogen signaling is 
blocked. Also, detrimental effects of stress are 
blocked in males when estrogen signaling is 
activated (Jacobs et al., 2015: Yuen et al., 2016). 
 Blocking estrogen synthesis enzyme aromatase 
with formestane in pre-frontal cortex (PFC) 
showed stress-induced glutamatergic deficits and 
memory impairment in female rats. This suggests 
that the female rodent PFC has an endogenous 
capacity to generate estrogen that provides 
protection against sub-chronic repeated stress. 
However, there is gender differences in response 
to stressors and they are modulated by hormonal 
status. However exogenous administration of 
estrogen seems to increase resilience to stress 
and preserve hippocampal functioning in rats 
(Cohen and Yehuda, 2011: Bredemann and 
McMahon, 2014).   
Although animal studies assessing 
electrophysiological, biochemical and behavioral 
markers for sex hormonal impacts on the 
glutamatergic system provide useful insights on 
underlying mechanisms, extrapolation to humans 
is difficult. Some of the beneficial effects of 
estrogen on cognitive function have also been 
shown in humans. Pre-menopausal women who 
were treated with a gonadotropin releasing 
hormone analog which chemically suppressed 
ovarian function experienced significant 
deterioration of mood and worsening of 
performance in working memory tasks (Freeman 
et al., 2006: Grigorova and Sherwin, 2006: 
Soares, 2014).  
A large number of studies with behavioral testing 
during hormonal transitions such as the 
menstrual cycle or post-menopause, point toward 
an estrogen-dependent improvement in memory 
but the neurochemical pathways underlying these 
changes remain to be identified. A useful 
approach to assess glutamate release in vivo in 
humans might be a pharmacological stimulation 
of the glutamatergic system with positron 
emission tomography (PET) using a glutamate-
receptor radio ligand. In conjunction with MR-
Imaging it could link glutamate release to brain 
activation during working memory tasks 
(Mcewen et al., 2012). Such methods may lead to 
a better understanding of the interaction between 
sex hormones and glutamatergic 
neurotransmission in humans (Holmseth et al., 
2012: Li and Huang, 2014). 




Estrogen and gamma-aminobutyric-acid 
interaction 
Gamma-amino butyric acid (GABA) is the most 
abundant and widely distributed inhibitory 
neurotransmitter in the Central Nervous System 
(CNS). GABAergic neurotransmission through 
interneurons is known to modulate local neuronal 
circuits through activation of dopaminergic and 
serotonergic neurons. GABAergic interneurons 
can be differentiated into two types, each acting 
through its receptor-subtype. GABA receptors 
are highly distributed in cortical, hippocampal, 
thalamic, basal ganglia and cerebellar structures 
(Sieghart and Sperk, 2002: Zhou and Danbolt, 
2013). 
GABAA receptors mediate major inhibitory 
GABAergic actions in the central nervous system 
(CNS) and are putative sites for ovarian hormone 
effects. Estrogen modulates the dynamics of 
surface GABAA receptors hence efficacy of 
inhibition through a postsynaptic mechanism 
(Mukherjee et al., 2017). Whereas estrogen 
seems to suppress GABA inhibitory input, 
progesterone and its neuroactive metabolites 
(allopregnanolone and pregnanolone) seem to 
facilitate GABAergic transmission through their 
action at GABAA receptors. Allopregnanolone 
acts like a positive modulator and potentiates the 
inhibitory action of GABA by increasing channel 
openings of the GABA-gated chloride channels 
and augmenting other inhibitory neuronal 
responses to GABA. This facilitation of GABA-
mediated Chloride ion current can result in 
inhibitory effects on neuronal function (Murphy 
et al., 1998a: Marshal, 2008). 
Estrogen and dopamine interaction 
Dopamine (DA) is a key neurotransmitter that is 
implicated in motor control, learning, motivation, 
reward, decision-making and working memory. 
Brain areas that show rich dopaminergic 
innervation include the striatum, substantia nigra 
and hypothalamus. Estrogen can impact 
dopaminergic neurotransmission through a 
multitude of mechanisms which include: 
synthesis, release, degradation and pre-and 
postsynaptic receptor transmissions (Quinlan et 
al., 2013). There is evidence for stimulating as 
well as inhibiting effects of estrogen on 
dopaminergic neurotransmission. The impact of 
estrogen on the DA-system depends on dose as 
well as time of testing, mode of administration, 
duration of exposure, and time after exposure. 
Estrogen has an overall facilitating effect on 
dopaminergic neurotransmission. Priming with 
estrogen can also influence the impact of 
progesterone on dopaminergic transmission 
(Barth et al., 2015). 
Recent studies report on the interaction between 
estrogen and dopamine on cognitive domains, 
such as decision-making, fear extinction and 
memory. There seems to be an agreement that 
estradiol affects decision-making toward smaller, 
more accessible rewards and a low-estrogen state 
during fear extinction is detrimental for an 
optimal freezing suppression after extinction, 
which is mediated by DA1-receptor signaling 
and that memory is mediated by the interaction 
of estradiol and dopamine in the dorsal striatum. 
Thus, optimal signaling may depend on the levels 
of estrogen to best interact with dopamine levels 
in the median range for optimal striatal function 
and optimal performance during a task (Rey et 
al., 2014). 
Several neuropsychiatric pathologies that display 
a substantial sexual dimorphism have been linked 
to abnormal dopaminergic function, such as 
schizophrenia, Parkinson's, or Alzheimer's 
disease. Thus, a better understanding of the 
interaction between estrogen and dopaminergic 
neurotransmission could help to improve 
pharmacological treatment regimens for these 
diseases and significantly impact women's 
mental health (Reeves et al., 2009). 
Estrogen and serotonin interaction 
The effect of estrogen on serotonin expression 
seems to depend on several factors such as: 
receptor subtype, brain area and duration of 
estrogen treatment.  Chronic estrogen 
administration has been found to increase 
tryptophan hydroxylase (TPH) messenger 




ribonucleic acid (mRNA).  TPH is a serotonin 
synthesizing enzyme. These enzymes include: 5-
hydroxytryptamine 2A (5-HT2A) mRNA levels in 
brain areas relevant for the control of mood, 
mental state and cognition and 5-
hydroxytryptamine transmission (5-HTT) mRNA 
(Wu et al., 2019). However, acute estrogen 
treatment leads to decrease in mRNA related to 
serotonergic neurotransmission. For instance, 5-
HT1B auto-receptor mRNA in dorsal raphe and 
Mono amino oxidase A (MAO A) mRNA 
activity are decreased after estrogen treatment 
(Amidfar et al., 2016). Furthermore, acute 
estrogen administration decreases 5-HTT mRNA 
levels and 5-HT1A mRNA levels and binding. 
The latter effect disappears after a more chronic 
treatment-regimen. Thus, assigning the effects of 
estrogen on serotonin to a homogenous 
functional class of stimulation or inhibition 
seems not to be feasible (Michopoulos et al 
2011). 
 Extraneous activities of estrogen 
Apart from reproduction and modulations in the 
brain, estrogen has been implicated in many 
other bodily function: 
Effect of estrogen in cardiovascular system 
 Estrogen therapy in postmenopausal women 
decreases the serum levels of both total and low-
density lipoprotein (LDL) cholesterol and raises 
high-density lipoprotein (HDL) cholesterol and 
triglycerides by influencing the expression of 
hepatic Apo protein genes. Two estrogen 
receptor (ER) subtypes, ERα and ERβ, have been 
identified and are expressed in the vasculature. 
However, estrogen supplementation in 
ovariectomized monkeys reduces the formation 
of plaques independent of changes in total 
plasma cholesterol or HDL levels. In contrast, 
protection against the development of 
atherosclerotic plaques by estrogen in intact 
female monkeys is associated with a concomitant 
decrease in plasma HDL (Meyer et al., 2014). 
Estrogen enhances endothelium-dependent 
vesorelaxation through increased release of nitric 
oxide (NO) (Akinshita and Yu, 2012). Estrogen 
inhibits calcium influx and stimulates calcium 
efflux in vascular smooth muscle cells leading to 
endothelium-independent vasodilation. 
Endothelial regeneration, inhibition of 
endothelial apoptosis and inhibition of vascular 
smooth muscle cell migration and 
proliferation may account for the inhibitory 
effects of estrogen on neointima formation 
(Krom et al., 2007). Analyses of knockout mice 
for ERα and ERβ have provided more 
information regarding the molecular mechanism 
of estrogen’s action on the blood vessels. Recent 
progress in nuclear receptor research has also 
clarified the non-genomic action of estrogen on 
the vasculature such as the direct interaction of 
ERα with the regulatory subunit of 
phosphatidylinositol-3-OH kinase (Wu et al., 
2005: Akishita and Lu, 2012: Reslan et al., 
2013). 
Effect of estrogen on bones  
Estrogen has various actions that are related to 
bone development and bone maintenance. 
Aromatase expression in human bone has been 
demonstrated in osteoblasts, chondrocytes, and 
fibroblasts where they convert circulating 
androgens into estrogen (Gennari et al., 2004). In 
the bone of prepubertal animals, the locally 
synthesized estradiol stimulates epiphyseal 
maturation during the growth phase. However, in 
both males and females, the massive pubertal 
increase of estradiol leads to increased apoptosis 
of chondrocytes in the epiphyseal plate, causing 
chondrocyte depletion and hence, ossification 
and slow down of growth. In adults, estradiol 
increases bone formation and mineralization and 
reduces bone resorption, thus reducing the risk of 
osteoporosis (Zhong et al., 2011). 
Effect of estrogen on appetite 
There is a correlation between estradiol levels 
and appetite. Food intake is significantly 
decreased during the preovulatory period when 
estradiol levels are increasing. These actions are 
attributed to estradiol inhibiting appetite 
indirectly through cannabinoid receptors which 
are a class of cell membrane receptors in the 




guanoline protein-coupled superfamily located 
throughout the body involved in appetite, pain-
sensation, mood and memory (Mela et al., 2016). 
When estrogen receptors are blocked with 
estrogen receptor antagonist such as ICI182, 270, 
any action of estradiol on appetite is removed. 
Alternatively, appetite is influenced by the 
microbiome which are ecological communities of 
commensals, symbiotic and pathogenic 
microorganisms present in the gastrointestinal 
tract (GIT). Bacterial peptides signal hunger or 
satiation; which means that bacteria control the 
desire of an animal or humans to eat. 
Interestingly, locally synthesized estrogen 
produced in response to microbiome composition 
influence immune responses to the bacterial load 
(Blaut, 2015). 
Regulation of adrenal function by estrogen 
Estrogens stimulate adrenal cortex growth during 
development by promoting cell proliferation and 
enhancing steroidogenic activity by increasing 
steroidogenic acute regulatory (StAR) protein 
and steroidogenic factor-1(SF-1) expression in 
the adrenal gland. The steroidogenic acute 
regulatory protein, commonly referred to 
as StAR is a transport protein that regulates 
cholesterol transfer within the mitochondria. 
StAR is a rate limiting step in the production of 
steroid hormones. StAR is primarily present in 
steroid producing cells which includes: theca and 
luteal cells in the ovary, Leydig cells in the testis 
and cell network in the zona reticularis of the 
adrenal cortex (Roostaee et al., 2008).  There is 
need to transfer cholesterol from the outer 
mitochondrial membrane to the inner membrane 
where cytochrome P450scc enzyme 
(CYP11A1)  cleaves the cholesterol side chain, 
which is the first enzymatic step in all steroid 
synthesis. P450scc is a member of the 
cytochrome P450 superfamily of enzymes 
(family 11, subfamily A, polypeptide 1). 
The gene name is CYP11A1 (Choi et al., 2019). 
The aqueous phase between these two 
membranes cannot be crossed by the cholesterol. 
StAR is the carrier protein which mediates this 
process (Tyczewska et al., 2014). 
 In the fetal adrenal gland, estradiol and 
adrenocorticotropic hormone (ACTH) form as a 
positive regulatory loop in which estradiol 
increases ACTH secretion from adrenal cortex 
while ACTH increase estradiol in the ovary 
(Kariyazono et al., 2015) 
Effect of estrogen in pancreas 
Estradiol increases insulin gene expression and 
insulin content in β-cells of the pancreas. Also, 
estradiol increases β-cell proliferation during 
pancreatic development and recovery from injury 
and prevents apoptosis of β-cells upon 
inflammatory insult through estrogen receptor 
alpha (ERα) and estrogen receptor beta (ERβ) 
mediated pathways (Yuchi et al., 2015). 
Effect of estrogen in adipose tissue 
 Estradiol stimulates the production of high 
density lipoprotein cholesterol (HDL) and 
triglycerides in adipose tissues but decreases low 
density lipoprotein (LDL) production and fat 
deposition. However, in an experiment 
conducted by Barakat et al., 2016, both male and 
female aromatase-deficient (Cyp19KO) mice 
exhibited obesity and dyslipidemia proving that 
estradiol plays a beneficial role in lipogenesis. At 
the other hand, estradiol is indicted in the 
pathogenesis of breast cancer because adipose 
tissues proximal to the breast tumor exhibit 
higher aromatase activity than those distal to it 
(Miller, 1991: Rochira and Carani, 2009: Hess 
and Cooke, 2017) 
Effect of estrogen in the skin 
Aromatase expression in the skin occurs mainly 
in hair follicles and sebaceous glands. Estradiol 
enhances collagen synthesis, increases skin 
thickness, and stimulates blood flow in the skin. 
Estradiol also prolongs the anagen phase of the 
hair cycle and therefore enhances hair growth by 
increasing the synthesis of essential growth 
factors stimulating the proliferation of hair 
follicle cells. As a result estrogen is used in 




cosmetics as hair shampoo. But the danger is that 
the estrogen component of the cosmetic can 
induce premature development in the girl child 
and cause feminization in the male fish that 
comes in contact with it in fresh water during the 
germination period of the reproduction (Nelson 
and Bulun, 2001: Jobling et al., 2006: El-Safoury 
et al ., 2010). 
 Effect of estrogen in the liver 
In the liver, estradiol regulates protein synthesis, 
including lipoprotein and proteins responsible for 
blood clotting (factors II, VII, IX, X, 
plasminogen). Estrogen signaling is also essential 
in regulating glucose homeostasis, thus 
improving glucose tolerance and insulin 
sensitivity (Barros and Gustafsson, 2011). 
Estrogens are metabolized through hydroxylation 
by cytochrome P450 enzymes such as CYP1A1 
and CYP3A4 through conjugation by estrogen 
sulfotransferases and Uridine 5-diphospho-
glucoronyl transferases (UDP-glucoronyl 
transferases). In addition, estradiol is 
dehydrogenated by 17β-hydroxysteroid 
dehydrogenase into estrone which is less potent. 
These reactions occur primarily in the liver. 
Estrogen receptor beta (ERβ) is implicated in 
mediating the protective role that estradiol plays 
under pathogenic condition in the liver as it 
shows potent anti-proliferative and anti-
inflammatory properties (Iavaroneet al., 2003). 
ERβ is also known to mediate the anti-tumor 
action of estrogens in intrahepatic 
cholangiocarcinoma (Marzioni et al., 2012). 
Effect of estrogen in immunity 
Estrogens play an important role in the 
inflammatory response by regulating 
development, proliferation, migration, and 
apoptosis of immune cells. Lymphocytes have 
been shown to express estrogen receptors (ERα 
and ERβ), but the expression levels of both 
receptors vary among cell types. CD4＋ T-
lymphocytes (which are white blood cells that 
are an essential part of the human immune 
system. They are often referred to as CD4 cells, 
T-helper cells or T4 cells). They express ERα 
whereas B-lymphocytes express ERβ. However, 
CD8＋ T-lymphocytes which are lymphocytes 
that kill cancer cells, cells infected with virus 
and/or damaged cells express both receptors at 
low but equal levels (Uzhachenko and Shanker, 
2019). Estradiol inhibits lymphopoiesis and 
influences T helper (Th) lymphocyte responses 
inhibiting the production of Th1 cytokines such 
as interleukin-12 (IL-12) (which is produced by 
activated antigen-presenting cells; dendritic cells 
and macrophages. It promotes the development 
of Th1 responses), tumor necrosis factor-α (TNF-
α) and interferon gamma (IFN-γ); a dimerized 
soluble cytokine that is the only member of the 
type II class of interferon and stimulate Th2 anti-
inflammatory cytokine production such as 
interleukin-10 (IL-10), IL-4, and transforming 
growth factor-β (TGF-β) (Salem, 2004: Fabregat 
and Caballero-Diaz, 2018). Estradiol has also 
been shown to modulate the maturation, 
differentiation and migration of myeloid cells, 
including monocytes, macrophages, and dendritic 
cells. In effect, estradiol negatively impact on 
immune cells and affects both the innate and the 
adaptive immune systems, which may account 
for its contribution in diseases associated with 
immune disorder (Mackern-Oberti et al., 2017). 
Effect of estrogen post-partum 
  Estrogen levels decrease 100–1000-fold post-
partum. This dramatic hormonal change induce a 
cascade of signaling that also affects the brain 
(Schiller et al., 2015). A study investigating the 
neurochemistry of the female brain in the 
immediate postpartum period found a substantial 
whole-brain increase in Monoamine oxidase A 
(MAO-A) in the brain in the first week 
postpartum compared to women who had not 
recently been pregnant. MAO-A is an enzyme 
that metabolizes monoamines, such as serotonin, 
dopamine and noradrenaline. A significant 
increase in MAO-A has been proposed to be 
predictive for the recurrence of major depressive 
disorder. These findings in humans are in line 




with the inverse relationship between estrogen 
levels and MAO-A which has been observed in 
cell lines, as well as in rat and macaque models 
(Dowlati et al., 2017). The acute estrogen drop 
within the first week postpartum has been 
hypothesized to trigger the subsequent MAO-A 
peak that could explain the depressed mood that 
a majority of mothers experience during this 
time. Elevated MAO-A levels have also been 
found in prefrontal cortical regions and areas of 
the acuate nucleus in women with postpartum 
depression (PPD) and in women who do not meet 
criteria for a full PPD but report postpartum 
crying (Mbarak et al., 2019). Thus, the 
interaction between estrogen and MAO-A seems 
to be a crucial factor in balancing postpartum 
mood. Given the current lack of prevention 
strategies for PPD, translation of biological 
concepts to facilitate the normalization of MAO-
A levels in the brain, including potentially 
attenuating the acute hormonal withdrawal that 
can precede such an MAO-elevation, represents a 
promising line of research (Suda et al., 2008). 
Estrogenic deficiency  
In vertebrates, estrogen deficiency occur due 
among others to: hypogonadism which is caused 
by ovarian failure, hypopituitarism (which makes 
it difficult to synthesize FSH and LH), polycystic 
ovarian syndrome, anorexia nervosa, extreme 
endurance exercise training post-partum and 
during lactation (Hill et al., 2004: Arenas et al., 
2005). 
The symptoms commonly observed in estrogen 
deficiency include: fatigue, depression, 
amenorrhea, lack of concentration, urinary tract 
infections, mood swings, hot flashes, breast 
tenderness, painful sex due to lack of lubrication, 
osteoporosis due to decreased bone density, 
compulsive behavior in male and ultimately 
infertility (Hill et al., 2007: Pinna et al., 2008). 
Estrogen in disease 
Estrogen is implicated in the development or 
progression of numerous diseases such as 
osteoporosis, breast cancer, endometrial cancer, 
ovarian cancer, colorectal cancer, heart disease 
and neurodegenerative diseases. Most women 
who take singe hormones as hormone 
replacement therapy (HRT) run the risk of 
coming down with cancer. The longer women 
take HRT, the more the risk increases. However, 
with stoppage of the treatment, the risk factor 
wanes off and returns to pre-treatment state 
(Ivarone et al., 2003: Sohrabji and Lewis, 2006: 
Deschamps et al., 2010).  
Estrogen in Colorectal cancer 
Studies have shown that combining two 
hormones as hormone replacement therapy 
(HRT) lowers the risk of invasive colorectal 
cancer in postmenopausal women. The two 
hormones commonly combined are estrogen and 
progestin. However, combination HRT does not 
lower the risk of dying from colorectal cancer 
(Prossnitz and Barton, 2011).  
Estrogen in Treatment 
Synthetic estrogen has numerous uses in 
medicine. The most common and notable uses of 
estrogen are in birth control pills or 
contraceptives and in hormone replacement 
therapy in humans. Estrogen is also used as a tool 
in estrous synchronization in animals (Pal and 
Dar, 2020). In humans, women between the ages 
of 25 to 50 who are estrogen deficient are 
generally prescribed a high dose of estrogen. 
This can reduce the risk of bone loss, 
cardiovascular disease, and other hormonal 
imbalances. The actual dose will depend on the 
severity of the condition and the method of 
application (Harman, 2014). 
 Mode of administration of estrogen 
Estrogen can be administered through the oral 
route, intra vaginal, intra venous or topical. 
Estrogen therapy is only recommended for one to 
two years. This is because estrogen therapy may 
increase the risk of cancer (Grodstein et al., 
2006: Darabi et al., 2011).  
  
 




Estrogen in Livestock 
 Human circulating estrogen are affected by diet 
and medication. Animal derived foods are rich in 
cholesterol, saturated fat and proteins. 
Cholesterol is the precursor for steroid hormones. 
In effect, cholesterol rich food leads to increase 
in estrogenic synthesis. This information is 
buttressed by the fact that changing diet regimen 
from animal products to vegetables in humans 
resulted in a significant reduction in estrogen 
(Carruba et al., 2006).  
However, synthetic estrogens are used as growth 
promoters and anabolic agents for efficient 
conversion of feed into meat in livestock and 
poultry. These hormones mimic the action of 
endogenous estrogens and initiate signal 
cascades out of membranes of the alimentary 
tract which affects the physiology of consumers 
especially in pubertal females (Lykholat et al., 
2016). 
Most cattle producers in the United States of 
America, use hormone implants to improve 
production efficiency. Some of these hormones 
approved by Food and Drug Administration 
include: estradiol, progesterone, testosterone, 
trenbolone acetate and zeranol. It is important to 
note that implants reduce greenhouse gas 
emission, energy use, water use and reactive 
nitrogen loss when compare to beef raised 
without growth promoting hormones (Beef 
News, 2019). 
Though implanted animals release minimal 
quantity of estrogen; about one nanogram per 
three-ounce serving when compared to non-
implanted animals, some consumers of such meat 
especially the bone complain of massive weight 
gain (Okwudiri, 2020, Oral communication). 
This is understandable because for growth to 
occur, most of the estradiol released from the 
pellet accumulate in the bones and induce the 
periosteum to become osteoprogenitor (bone 
forming) cell which eventually give rise to 
osteoblasts at the point of ossification of the 
cartilage to become bone (Goff, 2015). 
 
CONCLUSION AND RECOMMENDATION 
Estrogen in women is responsible for women to 
multitask with ease (Wei et al., 2014). 
Estrogen-dependent improvement in memory is 
observed but the neurochemical pathways 
underlying these changes have not been 
identified, therefore I recommend that 
researchers should turn their attention towards 
this vacuum with a view to fill it. 
Postpartum depression (PPD) is a common 
occurrence in primipartum women (first 
parturition). However, it is not certain whether 
estrogen drop postpartum is a sequel to PPD due 
to increase in Monoamine Oxidase. Hence I 
suggest that researchers should establish the 
actual cause of PPD whether it is hormone 
induced or psychopathic or both by treating post 
parturient females with Gonadotropin Releasing 
Hormone, or Follicle Stimulating Hormone or 
Luteinizing Hormone which ultimately leads to 
increase in estrogen secretion. 
Apart from United States of America that are 
clear about the use of hormone in livestock 
production, other countries should report drug 
use in animal production so that consumers will 
beware the consumption of some parts like the 
bone in order to avoid weight increase arbitrarily. 
This review is just to bring out estrogenic 
functions aside from reproduction. I suggest that 
a critical review of estrogen should be done to 
harness the progress made so far with estrogen 
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